80年代土耳其译制电影,80年代外国电影|80年代外国电影有哪些_80年代外国经典电影在线播放地址是多少?

[1]林珊珊綜述,趙愛萍審校.糖尿病腎臟疾病相關(guān)信號(hào)通路及其中醫(yī)藥調(diào)控的研究進(jìn)展[J].福建醫(yī)藥雜志,2024,46(02):131-135.[doi:10.20148/j.fmj.2024.02.036]
點(diǎn)擊復(fù)制

糖尿病腎臟疾病相關(guān)信號(hào)通路及其中醫(yī)藥調(diào)控的研究進(jìn)展()
分享到:

《福建醫(yī)藥雜志》[ISSN:1002-2600/CN:35-1071/R]

卷:
46
期數(shù):
2024年02期
頁(yè)碼:
131-135
欄目:
綜述與講座
出版日期:
2024-04-15

文章信息/Info

文章編號(hào):
1002-2600(2024)02-0131-05
作者:
林珊珊1綜述趙愛萍2審校
1 福建中醫(yī)藥大學(xué),福州 350122; 2 福建中醫(yī)藥大學(xué)附屬人民醫(yī)院,福州 350004
關(guān)鍵詞:
糖尿病腎臟疾病 中醫(yī)藥 信號(hào)通路 作用機(jī)制
分類號(hào):
R259
DOI:
10.20148/j.fmj.2024.02.036
文獻(xiàn)標(biāo)志碼:
A
摘要:
糖尿病腎臟疾病(diabetic kidney disease,DKD)是糖尿病發(fā)展到后期常見的一種慢性微血管并發(fā)癥,也是導(dǎo)致慢性腎臟疾病進(jìn)展至終末期的主要原因。代謝失衡、氧化應(yīng)激、慢性炎癥、腎臟纖維化等相關(guān)信號(hào)通路已成為近年研究糖尿病腎臟疾病作用機(jī)制的熱點(diǎn)。DKD的傳統(tǒng)治療難以取得滿意的臨床療效,研究發(fā)現(xiàn)中醫(yī)藥可通過(guò)干預(yù)信號(hào)通路發(fā)揮抗炎、抗氧化、抗纖維化等功效,對(duì)DKD的臨床治療具有顯著優(yōu)勢(shì)。該文闡述近年來(lái)DKD相關(guān)信號(hào)通路及中醫(yī)藥調(diào)控的研究進(jìn)展,希望能夠?yàn)樘悄虿∧I臟疾病的發(fā)病機(jī)制及治療提供新思路。

參考文獻(xiàn)/References:

[1] 黨佳蓉,黨琳慧,郭煦妍,等.糖尿病腎病的發(fā)病機(jī)制研究[J].醫(yī)學(xué)信息,2022,35(17):161-165.
[2] WILLEMSEN S,HARTOG J W L,HEINER-FOKKEMA M R,et al.Advanced glycation end-products,a pathophysiolo-gical pathway in the cardiorenal syndrome[J].Heart failure reviews,2012,17(2):221-228.
[3] YAMAGISHI S,MATSUI T.Advanced glycation end products,oxidative stress and diabetic nephropathy[J].Oxidative medicine and cellular longevity,2010,3(2):101-108.
[4] CUI Q Q,LI X M,XIE Y.Study on the mechanism of warming yang and reducing turbidity decoction in the treatment of diabetic kidney disease based on network pharmacology[J].Medicine,2022,101(39):e30728.
[5] MA X,HAO C,YU M,et al.Investigating the molecular mechanism of quercetin protecting against podocyte injury to attenuate diabetic nephropathy through network pharmacology,microarraydata analysis,and molecular docking[J].Evidence-based complementary and alternative medicine:eCAM,2022,2022:7291434.
[6] CHUNG H,SEO E,JUN H S.Effects of Psoralea corylifolia L.seed extract on AGEs-induced cell proliferation and fibrotic factor expression in mesangial cells[J].Experimental and therapeutic medicine,2021,22(5):1332.
[7] HARDIE D G.AMPK:a key regulator of energy balance in the single cell and the whole organism[J].International journal of obesity,2008,32(4):S7-S12.
[8] RUDERMAN N B,CARLING D,PRENTKI M,et al.AMPK,insulin resistance,and the metabolic syndrome[J].The Journal of clinical investigation,2013,123(7):2764-2772.
[9] SAHA A K,XU X J,BALON T W,et al.Insulin resistance due to nutrient excess:is it a consequence of AMPK downregulation?[J].Cell cycle,2011,10(20):3447-3451.
[10] 薛劍,喬晨.紫蘇葉提取物通過(guò)AMPK/mTOR自噬信號(hào)通路改善糖尿病腎病大鼠腎臟損傷研究[J].中醫(yī)藥學(xué)報(bào),2023,51(9):18-22.
[11] 王江俠,楊麗霞,米登海,等.當(dāng)歸多糖對(duì)糖尿病腎病KK-Ay小鼠腎臟AMPK信號(hào)通路及線粒體自噬的影響[J].中草藥,2023,54(10):3189-3196.
[12] 宋珂,宋丹,宋純東,等.基于Keap1/Nrf2/ARE通路探討益氣養(yǎng)陰活血方對(duì)糖尿病腎病大鼠的腎臟保護(hù)作用機(jī)制[J].時(shí)珍國(guó)醫(yī)國(guó)藥,2023,34(5):1049-1052.
[13] ZHANG J,ZHAO X,ZHU H,et al.Crocin protects the renal tubular epithelial cells against high glucose-induced injury and oxidative stress via regulation of the SIRT1/Nrf2 pathway[J].Iranian Journal of Basic Medical Sciences,2022,25(2):193-197.
[14] INOGUCHI T,YU H Y,IMAMURA M,et al.Altered gap junction activity in cardiovascular tissues of diabetes[J].Medical Electron Microscopy,2001,34(2):86-91.
[15] OSICKA T M,YU Y,PANAGIOTOPOULOS S,et al.Prevention of albuminuria by aminoguanidine or ramipril in streptozotocin-induced diabetic rats is associated with the normalization of glomerular protein kinase C[J].Diabetes,2000,49(1):87-93.
[16] SCIVITTARO V,GANZ M B,WEISS M F.AGEs induce oxidative stress and activate protein kinase C-βII in neonatal mesangial cells[J].American Journal of Physiology-Renal Physiology,2000,278(4):F676-F683.
[17] DUNLOP M.Aldose reductase and the role of the polyol pathway in diabetic nephropathy[J].Kidney international,2000,58:S3-S12.
[18] 夏青松,周儷珊,吳凡,等.胡蘆巴丸調(diào)控氧化應(yīng)激通路改善大鼠糖尿病腎病的實(shí)驗(yàn)研究[J].世界中醫(yī)藥,2021,16(19):2831-2838.
[19] 趙苗鑫,胡相卡,董蘇敏,等.紅花黃色素對(duì)糖尿病腎病小鼠腎的保護(hù)作用及機(jī)制研究[J].中國(guó)比較醫(yī)學(xué)雜志,2021,31(8):76-81.
[20] OECKINGHAUS A,GHOSH S.The NF-κB family of transcription factors and its regulation[J].Cold Spring Harbor perspectives in biology,2009,1(4):a000034.
[21] RYBICKI B A,SADASIVAN S M,CHEN Y,et al.Growth and differentiation factor 15 and NF-κB expression in benign prostatic biopsies and risk of subsequent prostate cancer detection[J].Cancer Medicine,2021,10(9):3013-3025.
[22] ZHAO W,HE C,JIANG J,et al.The role of discoid domain receptor 1 on renal tubular epithelial pyroptosis in diabetic nephropathy[J].The Korean Journal of Physiology & Pharmacology:Official Journal of the Korean Physiological Society and the Korean Society of Pharmacology,2022,26(6):427-438.
[23] 池楊峰,劉爽,黃潔波,等.黃芪湯通過(guò)TLR4/NF-κB信號(hào)通路改善糖尿病腎病大鼠炎癥反應(yīng)的研究[J].臨床腎臟病雜志,2022,22(1):39-45.
[24] 張旭東,任桂靈,陳慧慧,等.漢黃芩素調(diào)控TLR4/MAPK/NF-κB信號(hào)通路對(duì)糖尿病腎病大鼠腎纖維化的影響[J/OL].中國(guó)藥理學(xué)通報(bào),2023(10):1840-1846.
[25] HUANG X,LIU G,GUO J,et al.The PI3K/AKT pathway in obesity and type 2 diabetes[J].International Journal of Biological Sciences,2018,14(11):1483.
[26] ZENG L F,XIAO Y,SUN L.A glimpse of the mechanisms related to renal fibrosis in diabetic nephropathy[J].Renal Fibrosis:Mechanisms and Therapies,2019,1165:49-79.
[27] SANAJOU D,BAHRAMBEIGI S,ASLANI S.β-LAPachone is renoprotective in streptozotocin-induced diabetic mice via regulating the PI3K/Akt/mTOR signaling pathway[J].Iranian Journal of Basic Medical Sciences,2021,24(5):650-656.
[28] LU Q,WANG W W,ZHANG M Z,et al.ROS induces epithelialmesenchymal transition via the TGFβ1/PI3K/Akt/mTOR pathway in diabetic nephropathy[J].Experimental and Therapeutic Medicine,2019,17(1):835-846.
[29] HU Y,WANG S X,WU F Y,et al.Effects and mechanism of Ganoderma lucidum polysaccharides in the treatment of diabetic nephropathy in streptozotocin-induced diabetic rats[J].BioMed Research International,2022,2022:4314415.
[30] 喬進(jìn),趙彥,陳霞,等.基于PI3K/Akt/FoxO1通路探討大黃酸對(duì)2型糖尿病大鼠腎損傷的作用[J].中成藥,2023,45(2):609-613.
[31] MIYAZONO K,TEN DIJKE P,HELDIN C H.TGF-beta signaling by Smad proteins[J].Adv Immunol,2000,75:115-157.
[32] 周靖,郭洋洋,陸春紅,等.藏紅花素對(duì)糖尿病腎病大鼠腎纖維化的影響及機(jī)制研究[J].天津中醫(yī)藥,2023,40(4):513-517.
[33] LIN H C H,PAUL C R,KUO C H,et al.Glycyrrhiza uralensis root extract ameliorates high glucose-induced renal proximal tubular fibrosis by attenuating tubular epithelial-myofibroblast transdifferentiation by targeting TGF-β1/Smad/Stat3 pathway[J].Journal of Food Biochemistry,2022,46(5):e14041.
[34] Recio C,Lazaro I,Oguiza A,et al.Suppressor of cytokine signaling-1 peptidomimetic limits progression of diabetic nephropathy[J].Journal of the American Society of Nephro-logy:JASN,2017,28(2):575-585.
[35] CHEN D,LIU Y,CHEN J,et al.JAK/STAT pathway promotes the progression of diabetic kidney disease via autophagy in podocytes[J].European Journal of Pharmacology,2021,902:174121.
[36] GAO C,FEI X,WANG M,et al.Cardamomin protects from diabetes-induced kidney damage through modulating PI3K/AKT and JAK/STAT signaling pathways in rats[J].International Immunopharmacology,2022,107:108610.
[37] 陳彥旭,金智生,姜曉雪,等.基于JAK2/STAT3信號(hào)通路探討紅芪多糖對(duì)糖尿病腎病db/db小鼠作用機(jī)制[J].中國(guó)實(shí)驗(yàn)方劑學(xué)雜志,2023,29(13):65-71.

備注/Memo

備注/Memo:
基金項(xiàng)目:福建省衛(wèi)生健康中青年骨干人才培養(yǎng)項(xiàng)目(2020GGA062); 全國(guó)名老中醫(yī)藥專家傳承工作室(國(guó)中醫(yī)藥人教函〔2022〕75號(hào))
通信作者:趙愛萍,Email:[email protected]
更新日期/Last Update: 2024-04-15